Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 3
2005 2
2006 3
2007 1
2010 2
2011 3
2012 6
2013 7
2014 6
2015 7
2016 5
2017 9
2018 6
2019 7
2020 8
2021 9
2022 7
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Correction of Darwin's Tubercle with Plasma Exeresis.
Valeriani R, Firmani G, Valeriani M. Valeriani R, et al. Among authors: valeriani m. Plast Reconstr Surg Glob Open. 2022 Oct 5;10(10):e4556. doi: 10.1097/GOX.0000000000004556. eCollection 2022 Oct. Plast Reconstr Surg Glob Open. 2022. PMID: 36212084 Free PMC article.
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE).
Ingrosso G, Ponti E, Francolini G, Caini S, Fondelli S, Santini R, Valeriani M, Rago L, Duroni G, Bruni A, Augurio A, Tramacere F, Trippa F, Russo D, Bottero M, Tamburo M, Parisi S, Borghesi S, Lancia A, Gomellini S, Scoccianti S, Stefanacci M, Vullo G, Statuto T, Miranda G, Santo B, Di Marzo A, Bellavita R, Vinciguerra A, Livi L, Aristei C, Bertini N, Orsatti C, Detti B. Ingrosso G, et al. Among authors: valeriani m. Radiol Med. 2024 Apr;129(4):643-652. doi: 10.1007/s11547-024-01782-2. Epub 2024 Feb 19. Radiol Med. 2024. PMID: 38369638 Free PMC article.
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis.
Valeriani M, Detti B, Fodor A, Caini S, Borghesi S, Trippa F, Triggiani L, Bruni A, Russo D, Saldi S, Di Staso M, Francolini G, Lancia A, Marinelli L, Di Muzio N, Aristei C, Livi L, Magrini SM, Ingrosso G. Valeriani M, et al. Radiol Med. 2022 Jan;127(1):108-116. doi: 10.1007/s11547-021-01424-x. Epub 2021 Nov 8. Radiol Med. 2022. PMID: 34748151
Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study.
Gacci M, Marchioni M, DE Francesco P, Natoli C, Calabrò F, Losanno T, Gianmartin C, Serni S, Doni L, DE Nunzio C, DE Tursi M, Valeriani M, Giacinti S, Álvarez-Maestro M, Scarcia M, Ludovico GM, Del Bene G, Simone G, Ferriero M, Tuderti G, Bove P, Laudisi A, Carrieri G, Cormio L, Verze P, LA Rocca R, Falsaperla M, Frantellizzi V, Greco F, DI Nicola M, Schips L, Cindolo L. Gacci M, et al. Among authors: valeriani m. Minerva Urol Nephrol. 2021 Aug;73(4):489-497. doi: 10.23736/S2724-6051.20.03723-6. Epub 2020 Aug 4. Minerva Urol Nephrol. 2021. PMID: 32748613 Free article.
88 results